A new study of health care workers who felt well enough to return to work after contracting Covid-19 found that many continued to test positive on rapid tests—even after they had isolated for the CDC's recommended five-day isolation period.
Clinical trials for omicron-specific Covid-19 boosters are currently underway, but a new preprint study published Friday in bioRxiv suggests that Moderna's omicron-specific booster "may not provide greater immunity or protection" than its current Covid-19 vaccine.
Covid-19 cases have been dropping over the past two weeks in 49 states, according to data from Johns Hopkins University, and hospitalizations are decreasing as well, leading many states to start scaling back indoor and school mask mandates.
According to a draft report from the Institute for Clinical and Economic Review, the cost of currently available Covid-19 outpatient treatments, including monoclonal antibodies and antiviral pills, are "reasonably aligned" with their benefits for patients. See each treatment's cost-effectiveness ratio on our interactive chart, and read Advisory Board's take on how the definition of 'value' is expanding.
Writing for the Harvard Business Review, Kaitlin Woolley and Marissa Sharif identify three key factors that can pull employees down the social media "rabbit hole" while on the job—and suggest strategies about how best to "get back to work."
A Virginia judge on Friday temporarily blocked Gov. Glenn Youngkin's executive order to make mask optional in schools, in today's bite-sized hospital and health industry news from Oklahoma and Virginia.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.